Warning Letter Cites Thoratec For Inadequate Response To A Patient Death
This article was originally published in The Gray Sheet
Executive Summary
FDA outlines Thoratec's alleged late reporting and inadequate investigation of a patient death that may have been related to the HeartMate II left ventricular assist device.